Status:
SUSPENDED
Imagery Enhanced Cognitive Bias Modification for Chronic Worry
Lead Sponsor:
Toronto Metropolitan University
Collaborating Sponsors:
Ministry of Research, Innovation and Science, Ontario
Conditions:
Excessive Worry
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
People who experience high levels of worry often have mental habits that fuel their worry. One mental habit of interest to researchers is the tendency to assess situations and experiences in a very ne...
Detailed Description
In pathological worry, the tendency to assess situations and experiences in a very negative way even when it is possible the situation may turn out to be neutral or even positive is suggested to fuel ...
Eligibility Criteria
Inclusion
- Score of 62 or higher on the Penn State Worry Questionnaire.
- Endorsement of symptoms of Generalized Anxiety Disorder (e.g., excessive and uncontrollable worry) as per the DSM-5 description (American Psychiatric Association, 2013).
Exclusion
- Clinically significant suicidal ideation, intent, or plan
- Past or current history of psychosis, bipolar disorder, or substance or alcohol use disorder over the past 12 months
- Current psychological treatment or counseling unless this treatment is infrequent (once per month or less) or the participant has been receiving consistent weekly treatment for at least 12 weeks and still meets all other eligibility criteria
- Psychotropic medication with a change in dose in the past 12 weeks. If they have recently discontinued a psychotropic medication, they will be included if it has been at least 1 month since discontinuation, or 3 months if they had been taking fluoxetine. Use of benzodiazepines in the past 12 weeks will also exclude participants.
- Participants will be excluded if they report noncorrected hearing impairments as the training involves listening to audio recordings.
- Participants will be excluded if they do not have daily access to a computer with internet as this is required to complete the at home training.
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03855488
Start Date
August 20 2019
End Date
August 1 2022
Last Update
March 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryerson University
Toronto, Ontario, Canada, M5B 2K3